UB Paderborn / Katalog / Suche / in CDI

First‐in‐human study demonstrating the safety and clinical efficacy of novel anti‐IL‐17A monoclonal antibody CJM112 in moderate to severe plaque psoriasis

Journal of the European Academy of Dermatology and Venereology, 2021-05, Vol.35 (5), p.1143-1151

2021

Volltextzugriff (PDF)

Secukinumab, a fully human anti‐interleukin‐17A monoclonal antibody, exhibits low immunogenicity in psoriasis patients treated up to 5 years

Journal of the European Academy of Dermatology and Venereology, 2019-09, Vol.33 (9), p.1733-1741

2019

Volltextzugriff (PDF)

Non-invasive imaging demonstrates clinical features of ankylosing spondylitis in a rat adjuvant model: a case study

European journal of histochemistry, 2016-11, Vol.60 (4), p.2667-2667

2016

Volltextzugriff (PDF)

OP0202 Anti-IL-17A Treatment Blocks Inflammation and New Bone Formation in Experimental Spondyloarthritis in HLA-B27 Transgenic Rats

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.147-148

2015

Volltextzugriff (PDF)

Effect of IL-17A blockade with secukinumab in autoimmune diseases

Annals of the Rheumatic Diseases, 2013-04, Vol.72 (suppl 2), p.iii116-iii123

2013

Volltextzugriff (PDF)

SAT0142 Immunogenicity of the Novel Anti-Il-17A Antibody, Secukinumab, with Intravenous and Subcutaneous Dosing Regimens in Healthy Subjects and Patients

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A630-A630

2013

Volltextzugriff (PDF)

365 Secukinumab normalizes skin transcriptomes to a never-lesional state in new-onset psoriasis patients more rapidly than in chronic patients

Journal of investigative dermatology, 2022-12, Vol.142 (12), p.S243-S243

2022

Volltextzugriff (PDF)

Secukinumab demonstrates superiority over narrow‐band ultraviolet B phototherapy in new‐onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn study

Journal of the European Academy of Dermatology and Venereology, 2023-05, Vol.37 (5), p.1004-1016

2023

Volltextzugriff (PDF)

828 Early intervention with secukinumab may affect the establishment of tissue memory in psoriasis: Results from a DNA methylation analysis

Journal of investigative dermatology, 2023-05, Vol.143 (5), p.S142-S142

2023

Volltextzugriff (PDF)

Investigation of plaque psoriasis relapse after secukinumab withdrawal in patients from two phase III studies

Clinical and experimental dermatology, 2024-07, Vol.49 (8), p.793-800

2024

Volltextzugriff (PDF)

225 Interleukin-1β licenses interleukin-26 to potentiate type 2 skin inflammation

Journal of investigative dermatology, 2023-11, Vol.143 (11), p.S370

2023

Volltextzugriff (PDF)

Force-Mediated Kinetics of Single P-Selectin/Ligand Complexes Observed by Atomic Force Microscopy

Proceedings of the National Academy of Sciences - PNAS, 1998-10, Vol.95 (21), p.12283-12288

1998

Volltextzugriff (PDF)

Dupilumab treatment significantly improves skin barrier function in adult and adolescent patients with moderate to severe atopic dermatitis

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, Vol.142 (12), p.S243

2022

Volltextzugriff (PDF)

Early intervention with secukinumab may affect the establishment of tissue memory in psoriasis: Results from a DNA methylation analysis

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, Vol.143 (5), p.S142

2023

Volltextzugriff (PDF)

Histological validation of non-invasive imaging in an ankylosing spondylitis rat adjuvant model

European journal of histochemistry, 2016-10, Vol.60 (4)

2016

Volltextzugriff (PDF)

Amino acid sequence based PCR primers for amplification of rearranged human heavy and light chain immunoglobulin variable region genes

Journal of immunological methods, 1995-02, Vol.179 (2), p.203-214

1995

Volltextzugriff (PDF)

P-selectin glycoprotein ligand-1 supports rolling on E- and P-selectin in vivo

Blood, 2000-11, Vol.96 (10), p.3585-3591

2000

Volltextzugriff (PDF)

Automated baculovirus titration assay based on viable cell growth monitoring using a colorimetric indicator

BioTechniques, 2006-03, Vol.40 (3), p.282-292

2006

Volltextzugriff (PDF)

P-selectin glycoprotein ligand-1 supports rolling on E- and P-selectin in vivo

Blood, 2000-11, Vol.96 (10), p.3585-3591

2000

Volltextzugriff (PDF)

Long-term psoriasis control following secukinumab discontinuation indicates disease modification of moderate to severe psoriasis: Clinical and mechanistic results

AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, Vol.59, p.85

2018

Volltextzugriff (PDF)

Characterization of a Novel Proapoptotic Caspase-2- and Caspase-9-binding Protein

The Journal of biological chemistry, 2001-08, Vol.276 (31), p.29242-29250

2001

Volltextzugriff (PDF)

Functional cloning of Src-like adapter protein-2 (SLAP-2), a novel inhibitor of antigen receptor signaling

The Journal of experimental medicine, 2001-11, Vol.194 (9), p.1263-1276

2001

Volltextzugriff (PDF)

Expression of an NCA cDNA in NIH/3T3 cells yields a 110K glycoprotein, which is anchored into the membrane via glycosyl-phosphatidylinositol

Biochemical and biophysical research communications, 1989-06, Vol.161 (3), p.1126-1134

1989

Volltextzugriff (PDF)

Cloning of a Human UDP-galactose:2-Acetamido-2-deoxy-d-glucose 3β-Galactosyltransferase Catalyzing the Formation of Type 1 Chains

The Journal of biological chemistry, 1998-01, Vol.273 (1), p.433-440

1998

Volltextzugriff (PDF)

Protein analysis of NCA-50 shows identity to NCA cDNA deduced sequences and indicates posttranslational modifications

Biochemical and biophysical research communications, 1988-06, Vol.153 (3), p.1105-1115

1988

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

First‐in‐human study demonstrating the safety and clinical efficacy of novel anti‐IL‐17A monoclonal antibody CJM112 in moderate to severe plaque psoriasis

Secukinumab, a fully human anti‐interleukin‐17A monoclonal antibody, exhibits low immunogenicity in psoriasis patients treated up to 5 years

Non-invasive imaging demonstrates clinical features of ankylosing spondylitis in a rat adjuvant model: a case study

OP0202 Anti-IL-17A Treatment Blocks Inflammation and New Bone Formation in Experimental Spondyloarthritis in HLA-B27 Transgenic Rats

Effect of IL-17A blockade with secukinumab in autoimmune diseases

SAT0142 Immunogenicity of the Novel Anti-Il-17A Antibody, Secukinumab, with Intravenous and Subcutaneous Dosing Regimens in Healthy Subjects and Patients

365 Secukinumab normalizes skin transcriptomes to a never-lesional state in new-onset psoriasis patients more rapidly than in chronic patients

Secukinumab demonstrates superiority over narrow‐band ultraviolet B phototherapy in new‐onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn study

828 Early intervention with secukinumab may affect the establishment of tissue memory in psoriasis: Results from a DNA methylation analysis

Investigation of plaque psoriasis relapse after secukinumab withdrawal in patients from two phase III studies

225 Interleukin-1β licenses interleukin-26 to potentiate type 2 skin inflammation

Force-Mediated Kinetics of Single P-Selectin/Ligand Complexes Observed by Atomic Force Microscopy

Dupilumab treatment significantly improves skin barrier function in adult and adolescent patients with moderate to severe atopic dermatitis

Early intervention with secukinumab may affect the establishment of tissue memory in psoriasis: Results from a DNA methylation analysis

Histological validation of non-invasive imaging in an ankylosing spondylitis rat adjuvant model

Amino acid sequence based PCR primers for amplification of rearranged human heavy and light chain immunoglobulin variable region genes

P-selectin glycoprotein ligand-1 supports rolling on E- and P-selectin in vivo

Automated baculovirus titration assay based on viable cell growth monitoring using a colorimetric indicator

P-selectin glycoprotein ligand-1 supports rolling on E- and P-selectin in vivo

Long-term psoriasis control following secukinumab discontinuation indicates disease modification of moderate to severe psoriasis: Clinical and mechanistic results

Characterization of a Novel Proapoptotic Caspase-2- and Caspase-9-binding Protein

Functional cloning of Src-like adapter protein-2 (SLAP-2), a novel inhibitor of antigen receptor signaling

Expression of an NCA cDNA in NIH/3T3 cells yields a 110K glycoprotein, which is anchored into the membrane via glycosyl-phosphatidylinositol

Cloning of a Human UDP-galactose:2-Acetamido-2-deoxy-d-glucose 3β-Galactosyltransferase Catalyzing the Formation of Type 1 Chains

Protein analysis of NCA-50 shows identity to NCA cDNA deduced sequences and indicates posttranslational modifications

Suchergebnisse filtern